New Mexico Health Resources 21 st Annual Health Provider Retreat June 21, 2013 Joan Baumbach, MD, MPH, MS NM Department of Health
|
|
- Allison Collins
- 6 years ago
- Views:
Transcription
1 New Mexico Health Resources 21 st Annual Health Provider Retreat June 21, 2013 Joan Baumbach, MD, MPH, MS NM Department of Health
2 Provide overview of NM healthcare-associated infections (HAI) surveillance & prevention initiatives Review select examples of HAI outbreaks from medical & dental settings in New Mexico Understand role of medical & dental healthcare personnel in antimicrobial stewardship Edward Hopper ( ) Drug Store (1927) (detail) Oil on canvas (73.6 cm cm) The Museum of Fine Arts, Boston, Massachusetts, USA Bequest of John T. Spaulding,
3 Mandated by state regulation Developed by New Mexico Department of Health (NMDOH) Last updated February 29, 2012 List of diseases/conditions tracked statewide Communicable diseases: human and animal Occupational injury and illness Health conditions related to environmental exposures and certain injuries Adverse vaccine reactions Healthcare-associated infections Cancer Human papilloma virus Birth defects Genetic and congenital hearing screening
4 Anthrax* Haemophilus influenzae invasive infections* Rubella (including congenital) Avian or novel influenza* Measles Severe Acute Respiratory Syndrome (SARS)* Bordetella species* Meningococcal infections, invasive* Smallpox* Botulism (any type)* Plague* Tularemia* Cholera* Poliomyelitis, paralytic and non-paralytic Typhoid fever* Diphtheria* Rabies Yellow fever * Clinical specimens required to be sent to NM Dept. of Health Scientific Laboratory Division
5 Brucellosis Campylobacter infections* Clostridium difficile* Coccidioidomycosis Colorado tick fever Cryptosporidiosis Cysticercosis Cyclosporiasis Dengue E. coli 0157:H7 infections* E. coli, shiga-toxin producing (STEC) infections* Encephalitis, other Giardiasis Group A streptococcal invasive infections* Group B streptococcal invasive infections* Hantavirus pulmonary syndrome Hemolytic uremic syndrome Hepatitis A, acute Hepatitis B, acute or chronic Hepatitis C, acute or chronic Hepatitis E, acute Influenza-associated pediatric death Influenza, lab-confirmed hospitalization Legionnaires disease Leptospirosis Listeriosis* Lyme disease Malaria Mumps Necrotizing fasciitis* Psittacosis Q fever Relapsing fever Rocky Mountain spotted fever Salmonellosis* Shigellosis* St. Louis encephalitis infections Streptococcus pneumoniae invasive infections* Tetanus Trichinellosis Toxic shock syndrome Varicella Vibrio infections* West Nile Virus infections Western equine encephalitis infections Yersinia infections*
6 Newly reportable (2012) Central line-associated bloodstream infections in acute care hospital intensive care units Clostridium difficile infection Population-based surveillance Bernalillo County Facility-based laboratory reports into the National Healthcare Safety Network (NHSN) Voluntary reporting Healthcare personnel influenza vaccinations HAI-associated outbreaks
7 2005 Transmission of hepatitis B in oral surgery 2007 Transmission of Pseudomonas in urology clinic 2008 Transmission of group A Streptococcus in acute long-term care facility 2012 Lots of norovirus in healthcare facilities
8 Suspected source patient 1 st case Index patient 4 th case Hepatitis B surface antigen from both was type A/subtype adw2 Preliminary match led to contact other patients who had surgery same week/offer testing DNA base-pair sequence of two cases also matched
9 Modern, clean, anesthetic No re-use of needles or improper use of multi-dose vials Appropriate infection control practices Ideal 6-handed rather than 4-handed Floater in and out of sterile field Touching objects in sterile field (e.g., bloody gauze) and objects outside of sterile field (e.g., handle on sink, sterile water bottle) Sprayed and wiped surfaces after surgery No breakdown of procedure to account for transmission
10 HBV vaccination Apply standard precautions rather than universal precautions: Guidelines for Infection Control in Dental Health- Care Settings a1.htm Establish a routine and don t vary from it
11 Guidelines have changed over time Studies between showed no benefit of antibiotic prophylaxis, except in highest risk patients* Prosthetic heart valve, valve repair with prosthetic material, prior hx of infective endocarditis, many congenital heart abnormalities * Wilson W. et al., Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation 2007; 116:1736.
12 CASES DEFINITIONS Patient admitted to or discharged from facility Oct. 1, Feb. 3, 2008 Confirmed: GAS isolated from a usually sterile site Probable: GAS isolated from non-sterile site with clinically compatible syndrome when GAS was the predominant bacteria isolated CASES IDENTIFIED 10 cases 8 confirmed 7 bloodstream 1 bone/tissue 2 probable 2 deaths 1 bloodstream 1 wound
13 Confirmed Case Probable Case Number of case-patients Oct Nov Dec 2008-Jan Feb Universal Contact Precautions Instituted
14 # Cases 4 3 n = 23 Urologist temporarily ceased cystoscopies Urine Blood Both Jan Feb Mar Apr May Date of Diagnosis by Week, 2007
15 Patients Environmental Samples from 4 cystoscoped patients matched PFGE patterns from environmental samples A B A= 1 st rinse through cystoscope B = Isolate from cleaning brush
16 Responsible for ~ ½ of known foodborne illness outbreaks in U.S Important to identify outbreaks early 24 NM norovirus outbreaks identified in 2012 >50% in long-term care facilities Apply specific environmental and clinical prevention guidelines Do not prescribe antibiotics
17 # Cases Norovirus Outbreak at Facility X, NM, A pts B pts C pts D pts E pts F pts G pts H pts I pts
18 HAI are major public health problem Preventing HAIs is priority of CDC, other federal agencies, and states Until recently, last full-scale estimate of magnitude of HAIs was from 1970 s CDC s Study on the Efficacy of Nosocomial Infection Control (SENIC) 5.23% of hospitalized patients acquired HAI
19 Estimate HAI prevalence among inpatients in acute healthcare facilities Determine distribution of HAI by pathogen & major infection site Estimate prevalence & describe rationale for antimicrobial use in acute healthcare facilities
20 3 phases to survey Phase 1: single-city pilot, 2009 Phase 2: limited roll-out, 2010 Phase 3: full-scale survey, 2011
21 10 Emerging Infections Program (EIP) states engaged up to 25 facilities based on 3 strata of bed size Survey conducted on single day at each facility during May-August 2011 Eligible patients Acute care inpatients of any age Randomly selected beds on survey morning Up to 100 patients/beds sampled depending on bed size strata Findings HAI prevalence & antimicrobial use varies between states Final analyses pending details will be disseminated
22 20 general acute care facilities participated 892 patient records were surveyed Mean age 52.6 yrs, median 58.0 yrs Range 0-96 yrs 53.5% female, 46.5% male 44.3% White, 39.0% Hispanic, 9.4% American Indian
23 218 patients (24.4%) had urinary catheter 32 patients (3.6%) receiving mechanical ventilation 159 (17.8%) had a central line Among those with a central line 70 patients (44.0%) had PICC line 3 patients (1.9%) had femoral line 87 patients (54.7%) had other central line 3 patients (1.9%) had unknown line type
24 25 HAI detected among 22 patients At patient level, 2.5% (95% CI ) HAI prevalence 54.6% female, 45.5% male Mean age 61.5 yrs, median 70.5 yrs, (range yrs) 10 HAI attributed to critical care locations, 13 attributed to ward locations
25 HAI Major Type Frequency (n=25) Percent (%) Urinary tract infection 7 (4/7 CAUTI) 28.0 Pneumonia 6 (4/6 VAP) 24.0 Gastrointestinal tract infection Lower respiratory tract infection Surgical site infection Skin/soft tissue infection Bloodstream infection 1 (1/1 CLABSI) 4.0 Eye, ear, nose, throat infection 1 4.0
26 443 patients (49.7%, 95% CI ) reported to be on or scheduled for antimicrobials on survey day or day prior to survey day 433 patients (48.5%, 95% CI ) determined to actually have received antimicrobials 768 antimicrobials given (includes same antimicrobial given by different routes) Antimicrobials per patient: mean 1.8, median 2.0, range 1-8
27 Rationale Frequency (n=768) Percent (%) Treatment of active infection Surgical prophylaxis Medical prophylaxis Non-infectious None documented
28 Top 5 Therapeutic Sites Frequency (n=629) Percent (%) Lower respiratory tract infection Urinary tract infection Skin/soft tissue infection Gastrointestinal tract infection Bloodstream infection
29 Location of Infection Onset Frequency (n=629) Percent (%) Community Survey hospital Other healthcare facility Unknown 1 0.2
30 Top 1-10 Antimicrobials Frequency (n=768) Percent (%) Vancomycin Cefazolin Ceftriaxone Piperacillin/tazobactam Ciprofloxacin Metronidazole Clindamycin Azithromycin Levofloxacin Moxifloxacin
31 Point prevalence, one day in time Voluntary participation Only acute care general hospitals, may not be representative of all facilities Following NHSN definitions, clinical and surveillance definitions may vary Limited to documentation in medical records
32 Almost ½ of surveyed patients on antimicrobials Most antimicrobials being used for treatment of active infections Most active infections had community onset Small percent of HAI but variety of HAI types and organisms present
33 Overuse use of antibiotics/more MDROs Complex healthcare delivery systems Increasingly sick patients/patient transfers Increased environmental contamination risk Increased MDRO colonization pressure Increasing risk of transmission Lack of resources/institutional will to enforce recommendations Suboptimal infection control Controlling MDROs requires a multifaceted and multi-disciplinary effort
34 Nature Reviews: Drug Discovery. 2007: 6; 8-12.
35 New antibacterial agents approved in the United States, , per 5-year period From: Spellberg et al. Trends in Antimicrobial Drug Development: Implications for the Future CID 2004:38 (1 May)
36 Extendingthecure.org, Policy Brief #
37 Coordinated interventions designed to improve and measure the appropriate use of antimicrobials by promoting the selection of the optimal antimicrobial drug regimen, dose, duration of therapy, and route of administration Seeks to achieve optimal clinical outcomes related to antimicrobial use, minimize toxicity and other adverse events, reduce the costs of health care for infections, and limit the selection for antimicrobial resistant strains Across all healthcare settings
38 Right drug - check cultures for drug-bug mismatch Right reason - following published guidelines Right dose - renal and/or weight-adjusted Right formulation - consider switch to p.o. when ready Right timing - correct dosing interval or prophylactic timing Right duration - following published guidelines Right follow-up - monitor the patient Right consultation - know when you need help All without adverse consequences for the patient
39 Summarized in Patel D, et al. Antimicrobial Stewardship Programs: Interventions and Associated Outcomes. Expert Reviews of Anti-Infective Therapy 33 studies demonstrating cost savings or cost neutrality of programs 22 studies examining antimicrobial resistance and C. difficile outcomes 14 were able to demonstrate reduction in gramnegative resistance and/or C. difficile
40 Position statement of the Society for Healthcare Epidemiology of America (SHEA), IDSA, and the Pediatric Infectious Diseases Society of America (PIDS) Infectious Diseases Society of America (IDSA) practice and stewardship guidelines Stewardship Centers for Disease Control and Prevention (CDC) online CME modules and other tools:
41 Various definitions in the literature Resistance to > 1 antibiotics Resistance to > 1 class of antibiotics Resistance to all but one antibiotic or class Resistance to all antibiotics or classes Definitions influence how magnitude of the problems and outcomes are presented
42 Prevalence varies temporally, geographically, and by healthcare setting Antimicrobial resistance rates are strongly correlated with hospital size, tertiary-level care, and facility type MDROs in U.S. hospitals and medical centers have increased steadily last several decades Methicillin-resistant Staphylococcus aureus (MRSA) was first isolated in the United States in 1968 Other identified and increasing over time: Vancomycinresistant Enterococcus (VRE); multi-drug resistant tuberculosis (MDR-TB); Acinetobacter; Clostridium difficile; extended spectrum beta-lactamase [ESBL]-producing or intrinsically resistant gram-negative bacilli
43 Options for treatment are relatively limited Worse outcomes have been shown for VRE, Pseudomonas, Acinetobacter, Enterobacter, E. coli, K. pneumoniae MDROs associated with Increased morbidity and mortality Increased lengths of stay Increased cost
44 KPC is a class A β-lactamase Confers resistance to all β-lactams including extendedspectrum cephalosporins & carbapenems During past decade in US, KPC established in Enterobacteriaceae Most commonly in Klebsiella pneumoniae Healthcare and community acquired Felt by many to be more virulent than Acinetobacter or Pseudomonas
45 Pharmacology plays large role FDA safety labeling revisions in Dec for antimicrobials to warn of the risk for CDAD Hypertoxin-producing strains of C. difficile can be refractory to antimicrobial therapy Associated with increased morbidity & mortality May require colectomy, can cause death Opportunities to initiate/lead/join antimicrobial stewardship initiatives
46 4% 1% 10% 5% 53% One Two Three 27% Four Five Six One person each had 7, 8, or 9 different antibiotics * data; 2 weeks (2011) or 12 weeks (2012) prior to CDI diagnosis 2012 data are preliminary
47 30% 25% 20% 15% 10% 5% 0% * data; 2 weeks (2011) or 12 weeks (2012) prior to CDI diagnosis 2012 data are preliminary
48 Project goals Decrease Clostridium difficile infections (CDI) & CDI-related hospitalizations Increase CDI prevention best practices & antimicrobial stewardship practices Project partners Hospitals, community providers, nursing homes, dialysis centers, home health agencies, clinical labs, public health, healthcare quality improvement organization
49 Common Enterobacteriaceae include Klebsiella species and Escherichia coli (E. coli) CRE infections are most commonly seen in people with exposure to healthcare settings Some CRE bacteria have become resistant to almost all available antibiotics and can be deadly Among prevention approaches, important to only prescribe antibiotics when necessary
50 NMDOH is conducting active, populationbased CRE surveillance in Bernalillo County as part of national network Determine the extent of CRE Identify people most at risk for illness Measure trends in infections over time 2012 CDC CRE toolkit to assist healthcare facilities in preventing and controlling CRE:
51 View Farmington project antimicrobial stewardship webinars at: s4bugs.php Antimicrobial stewardship webinars will run again from Oct 2013 through April 2014 Project ECHO (Extension for Community Health Outcomes: weekly TeleECHO clinics) will be offering infectious disease management, infection control, antimicrobial stewardship to interested hospitals Send your hospital name and designated clinician contact to (Jeannie Boyle, RN) if you wish to join
52 24/7/ Joan Baumbach
1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection
Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection
More informationHealthcare-associated Infections and Antimicrobial Use Prevalence Survey
Healthcare-associated Infections and Antimicrobial Use Prevalence Survey Shamima Sharmin, M.B.B.S., MSc, MPH Emerging Infections Program New Mexico Department of Health Agenda Recognize healthcare-associated
More informationInfection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention
Highlights for the Medical Staff Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention Standard Precautions every patient every time a. Hand Hygiene b. Use of Personal Protective Equipment (PPE)
More informationWhat bugs are keeping YOU up at night?
What bugs are keeping YOU up at night? Barbara DeBaun, RN, MSN, CIC 26 th Annual Medical Surgical Nursing Conference South San Francisco, CA April 15, 2016 Objectives Describe the top three infectious
More informationDEPARTMENT OF HEALTH NOTICE OF FINAL RULEMAKING
DEPARTMENT OF HEALTH NOTICE OF FINAL RULEMAKING The Director of the Department of Health, pursuant to the authority set forth in Section 1 of An Act to authorize the Commissioners of the District of Columbia
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationPreventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier
More informationPreventing and Responding to Antibiotic Resistant Infections in New Hampshire
Preventing and Responding to Antibiotic Resistant Infections in New Hampshire Benjamin P. Chan, MD, MPH NH Dept. of Health & Human Services Division of Public Health Services May 23, 2017 To bring a greater
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationMulti-Drug Resistant Organisms (MDRO)
Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause
More informationAntibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011
Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond
More information11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:
Hospital-acquired Infections Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationAntibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship
Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship J. Hudson Garrett Jr., PhD, MSN, MPH, FNP-BC, PLNC, CDONA, IP-BC, GDCN, CDP, CADDCT, CALN, VA-BC, AS-BC,
More informationChallenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial
More informationMultidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?
Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical
More informationCommunity-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018
Community-Associated C. difficile Infection: Think Outside the Hospital Maria Bye, MPH Epidemiologist Maria.Bye@state.mn.us 651-201-4085 May 1, 2018 Clostridium difficile Clostridium difficile Clostridium
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationInfectious Disease in PA/LTC an Update. Karyn P. Leible, MD, CMD, FACP October 2015
Infectious Disease in PA/LTC an Update Karyn P. Leible, MD, CMD, FACP October 2015 Disclosures Dr. Leible has no financial disclosures relevant to this presentation. Introduction Objectives The participant
More informationHospital Acquired Infections in the Era of Antimicrobial Resistance
Hospital Acquired Infections in the Era of Antimicrobial Resistance Datuk Dr Christopher KC Lee Infectious Diseases Unit Department of Medicine Sungai Buloh Hospital Patient Story 23 Year old female admitted
More informationTaking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms
Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms Nimalie D. Stone, MD,MS Division of Healthcare Quality Promotion National
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationInfection Control of Emerging Diseases
2016 EPS Training Event Martin E. Evans, MD Director, VHA MDRO Program National Infectious Diseases Service Lexington, KY & Cincinnati, OH Infection Control of Emerging Diseases 2016 EPS Training Event
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationMDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC
MDRO s, Stewardship and Beyond Linda R. Greene RN, MPS, CIC linda_greene@urmc.rochester.edu Evolving Threat of Antimicrobial Resistance Why are MDROs important? Limited treatment options Associated with:
More informationHorizontal vs Vertical Infection Control Strategies
GUIDE TO INFECTION CONTROL IN THE HOSPITAL Chapter 14 Horizontal vs Vertical Infection Control Strategies Author Salma Abbas, MBBS Michael Stevens, MD, MPH Chapter Editor Shaheen Mehtar, MBBS. FRC Path,
More informationAntibiotic Stewardship in the LTC Setting
Antibiotic Stewardship in the LTC Setting Joe Litsey, Director of Consulting Services Pharm.D., Board Certified Geriatric Pharmacist Thrifty White Pharmacy Objectives Describe the Antibiotic Stewardship
More informationCommonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities
Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we
More informationKeeping Antibiotics Working: Nursing Leadership in Action
Keeping Antibiotics Working: Nursing Leadership in Action Pat McLaine, DrPH, MPH, RN Robyn Gilden, PhD, RN Department of Family and Community Health Maryland Nurses Association October 2016 US 2 million
More informationMDRO in LTCF: Forming Networks to Control the Problem
MDRO in LTCF: Forming Networks to Control the Problem Suzanne F. Bradley, M.D. Professor of Internal Medicine Division of Infectious Disease University of Michigan Medical School VA Ann Arbor Healthcare
More informationImplementing Antibiotic Stewardship in Rural and Critical Access Hospitals
National Center for Emerging and Zoonotic Infectious Diseases Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals Denise Cardo, MD Director, Division of Healthcare Quality Promotion,
More informationRecommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland
Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland A report by the Hospital Antimicrobial Stewardship Working Group, a subgroup of the
More informationUsing Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and
Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and Health-Care Associated Infections Overall Goals & Objectives:
More informationAntibiotic stewardship in long term care
Antibiotic stewardship in long term care Shira Doron, MD Associate Professor of Medicine Division of Geographic Medicine and Infectious Diseases Tufts Medical Center Boston, MA Consultant to Massachusetts
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationAntimicrobial stewardship: Quick, don t just do something! Stand there!
Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger
More informationAntibiotic Prophylaxis Update
Antibiotic Prophylaxis Update Choosing Surgical Antimicrobial Prophylaxis Peri-Procedural Administration Surgical Prophylaxis and AMS at Epworth HealthCare Mr Glenn Valoppi Dr Trisha Peel Dr Joseph Doyle
More informationDoes Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?
Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and
More informationThe Rise of Antibiotic Resistance: Is It Too Late?
The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the
More informationAntimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD
Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an
More informationAntibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University
Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine Mike Apley Kansas State University Changes in Food Animal Antibiotic Use How the uses of antibiotics in
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationIDSA GUIDELINES COMMUNITY ACQUIRED PNEUMONIA
page 1 / 5 page 2 / 5 idsa guidelines community acquired pdf IDSA/ATS Guidelines for CAP in Adults CID 2007:44 (Suppl 2) S29 such as blood and sputum cultures. Conversely, these cultures may have a major
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationCarbapenemase-Producing Enterobacteriaceae (CPE)
Carbapenemase-Producing Enterobacteriaceae (CPE) September 21, 2017 Maryam Khan Peel Public Health Madeleine Ashcroft Public Health Ontario Objectives Differentiate the acronyms related to CPE (CPE,CPO,CRE,CRO)
More informationSurveillance of Multi-Drug Resistant Organisms
Surveillance of Multi-Drug Resistant Organisms Karen Hoffmann, RN, MS, CIC Associate Director Statewide Program for Infection Control and Epidemiology (SPICE) University of North Carolina School of Medicine
More informationANTIBIOTIC RESISTANCE THREATS. in the United States, 2013
ANTIBIOTIC RESISTANCE THREATS in the United States, 2013 TABLE OF CONTENTS Foreword... 5 Executive Summary.... 6 Section 1: The Threat of Antibiotic Resistance... 11 Introduction.... 11 National Summary
More informationTABLE OF CONTENTS Foreword...5 Executive Summary...6 Section 1: The Threat of Antibiotic Resistance...11 Introduction...11 National Summary Data...
TABLE OF CONTENTS Foreword....5 Executive Summary....6 Section 1: The Threat of Antibiotic Resistance....11 Introduction....11 National Summary Data....13 Cycle of Resistance Infographics....14 Minimum
More informationImagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening
Multi-Drug Resistant Superbugs- What s the Big Deal? Toni Biasi, RN MSN MPH CIC Infection Prevention Indiana University Health Imagine A World Without Antibiotics A World Where Simple Infections can be
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationAntimicrobial Stewardship 101
Antimicrobial Stewardship 101 Betty P. Lee, Pharm.D. Pediatric Infectious Disease/Antimicrobial Stewardship Pharmacist Lucile Packard Children s Hospital Stanford Disclosure I have no actual or potential
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationSource: Portland State University Population Research Center (
Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:
More informationMike Apley Kansas State University
Mike Apley Kansas State University 2003 - Daptomycin cyclic lipopeptides 2000 - Linezolid - oxazolidinones 1985 Imipenem - carbapenems 1978 - Norfloxacin - fluoroquinolones 1970 Cephalexin - cephalosporins
More informationHealthcare-associated Infections Annual Report December 2018
December 2018 Healthcare-associated Infections Annual Report 2011-2017 TABLE OF CONTENTS INTRODUCTION... 1 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS... 2 MRSA SURVEILLANCE... 3 CLOSTRIDIUM
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationHuman health impacts of antibiotic use in animal agriculture
Human health impacts of antibiotic use in animal agriculture Beliefs, opinions, and evidence Peter Davies BVSc, PhD College of Veterinary Medicine, University of Minnesota, USA Terminology Antibiotic Compound
More informationAntimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS
Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives
More informationWhat is an Antibiotic Stewardship Program?
What is an Antibiotic Stewardship Program? Jane Rogers, R.N. Anne Messer, MPH Learning Session #4 August 15, 2017 National Nursing Home Quality Care Collaborative Change Package Change Bundle: To prevent
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationAntibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE
Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org
More informationPharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care
Pharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care Jennifer McCann, PharmD, BCCCP State Director of Clinical Pharmacy Services St. Vincent Health Indiana Conflicts of Interest No
More informationReady to Launch: Antimicrobial Stewardship for All!
Ready to Launch: Antimicrobial Stewardship for All! Lucas Schulz, PharmD, BCPS AQ ID Clinical Coordinator Infectious Diseases PGY2 Infectious Diseases Residency Program Director Disclosures Consultant
More informationAntibiotic Stewardship in the Neonatal Intensive Care Unit. Objectives. Background 4/20/2017. Natasha Nakra, MD April 28, 2017
Antibiotic Stewardship in the Neonatal Intensive Care Unit Natasha Nakra, MD April 28, 2017 Objectives 1. Describe antibiotic use in the NICU 2. Explain the role of antibiotic stewardship in the NICU 3.
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationMulti-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version
Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED 2018 Printed copies must not be considered the definitive version DOCUMENT CONTROL POLICY NO. IC-122 Policy Group Infection Control
More informationAntimicrobial Stewardship in the Hospital Setting
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor
More informationAppendix A. Reportable Disease Table
Appendix A. Reportable Disease Table Disease/Event Pathogen/Organism Time* Reporter 1 Specimen Acinetobacter baumannii, carbapenemresistant 5, 4-Metro (CRAB) Carbapenem-resistant Acinetobacter baumannii
More informationPhysician Rating: ( 23 Votes ) Rate This Article:
From Medscape Infectious Diseases Conquering Antibiotic Overuse An Expert Interview With the CDC Laura A. Stokowski, RN, MS Authors and Disclosures Posted: 11/30/2010 Physician Rating: ( 23 Votes ) Rate
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationCAVICIDE1. Technical Bulletin
CAVICIDE1 Technical Bulletin CaviCide1 is a multi-purpose disinfectant intended for use in cleaning, decontaminating and disinfecting hard non-porous, inanimate surfaces and non-critical instruments in
More informationMethicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives John Jernigan, MD, MS Alex Kallen, MD, MPH Division of Healthcare Quality Promotion Centers for Disease
More informationTABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process
TABLE OF CONTENTS Winnipeg Regional Health Authority Introduction Page Number 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process 2. WRHA Infection Prevention and Control
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationHealthcare Facilities and Healthcare Professionals. Public
Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:
More informationMHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative
MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative Place picture here Nov. 14, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Please use the chat box to ask questions!
More information8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM
Mary Moore, MS CIC MT (ASCP) Infection Prevention Coordinator Great River Medical Center, West Burlington REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM ABOUT
More informationObjectives. Basic Microbiology. Patient related. Environment related. Organism related 10/12/2017
Basic Microbiology Vaneet Arora, MD MPH D(ABMM) FCCM Associate Director of Clinical Microbiology, UK HealthCare Assistant Professor, Department of Pathology and Laboratory Medicine University of Kentucky
More informationAntimicrobial Stewardship:
Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of
More informationSurveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,
Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationNHSN 2015 Rebaseline and TDH Updates. Ashley Fell, MPH
NHSN 2015 Rebaseline and TDH Updates Ashley Fell, MPH Standardized Infection Ratio (SIR) SIR = Observed O HAIs Predicted P HAIs 2 National Baseline Years 2015 (New) NHSN Baseline All HAI Types: CLABSI,
More informationMICRO-ORGANISMS by COMPANY PROFILE
MICRO-ORGANISMS by COMPANY PROFILE 2017 1 SAPROPHYTES AND PATHOGENES SAPROPHYTES Not dangerous PATHOGENES Inducing diseases Have to be eradicated WHERE ARE THERE? EVERYWHERE COMPANY PROFILE 2017 3 MICROORGANISMS
More informationWhat s next in the antibiotic pipeline?
What s next in the antibiotic pipeline? Jennifer Tieu, Pharm.D., BCPS Clinical Pearls OSHP Spring Meeting Mercy Hospital April 13, 2018 Objective 2 Describe the drug class and mechanism of action of antibiotics
More informationAntibiotic Stewardship at MetroWest Medical Center. Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee
Antibiotic Stewardship at MetroWest Medical Center Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee Antibiotic Stewardship Committee Subcommittee of Pharmacy and Therapeutics. Also
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationCarbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S
Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S CRE Enterobacteriaceae (Gram Negative Bacilli) Citrobacter species Escherichia coli***
More informationGeriatric Mental Health Partnership
Geriatric Mental Health Partnership September 8, 2017 First, let s test your knowledge about antibiotics http://www.cdc.gov/getsmart/community/about/quiz.html 2 Get Smart Antibiotics Quiz Antibiotics fight
More informationDATA COLLECTION SECTION BY FRONTLINE TEAM. Patient Identifier/ Medical Record number (for facility use only)
Assessment of Appropriateness of ICU Antibiotics (Patient Level Sheet) **Note this is intended for internal purposes only. Please do not return to PQC.** For this assessment, inappropriate antibiotic use
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationAntibiotic Stewardship in the Hospital Setting
Antibiotic Stewardship in the Hospital Setting G. Evans, MD FRCPC Medical Director, Infection Prevention & Control Kingston General Hospital & Hotel Dieu Hospital EOPIC September 26, 2012 Stewardship stew-ard-ship
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationTelligen Outpatient Antibiotic Stewardship Initiative. The Renal Network March 1, 2017
Telligen Outpatient Antibiotic Stewardship Initiative The Renal Network March 1, 2017 Who is Telligen? What is the QIN-QIO Program? Telligen: The Medicare Quality Innovation Network (QIN)-Quality Improvement
More informationCollecting and Interpreting Stewardship Data: Breakout Session
Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline
More informationAntimicrobial stewardship in companion animals: Welcome to a whole new era
Antimicrobial stewardship in companion animals: Welcome to a whole new era John F. Prescott, University Professor Emeritus, Department of Pathobiology, University of Guelph, Guelph, Ontario NG 2W1 prescott@uoguelph.ca
More informationAppropriate Antimicrobial Use in California: The Path of Least Resistance
Appropriate Antimicrobial Use in California: The Path of Least Resistance BEACON Fall Exchange November 9, 2011 Kavita K. Trivedi, MD Healthcare Associated Infections Program California Department of Public
More informationVaccination as a potential strategy to combat Antimicrobial Resistance in the elderly
Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized
More information